SOLICITATION NOTICE
B -- Special Studies and Analysis
- Notice Date
- 2/6/2006
- Notice Type
- Solicitation Notice
- NAICS
- 621511
— Medical Laboratories
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 10401 Fernwood Drive, Suite 2NE70, MSC 4811, Bethesda, MD, 20817
- ZIP Code
- 20817
- Solicitation Number
- NOI6024
- Response Due
- 2/20/2006
- Archive Date
- 3/7/2006
- Description
- This is a combined synopsis/solicitation notice of intent for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are not being requested and a written solicitation will not be issued. The solicitation number for this acquisition is NOI6024 and the solicitation is being issued as a notice of intent. This solicitation document and its incorporated provisions are those in effect through Federal Acquisition Circular FAC 2005-06. The National Institute of Allergy and Infectious Diseases intend to negotiate on a sole-source basis using simplified acquisition procedures with the Canadian Immunodeficiency Research Collaborative of Toronto, Canada for rare HIV patient samples. NIAID investigators are studying the pathogenesis of HIV in infected individuals. A critical part of this research entails identification of molecules on CD8+ T cells of long-term non-progressors in whom viral replication is inhibited by the host immune system in the absence of anti-HIV therapy (Z01 A1000885-02 Immunologic and Virologic Strategies Directed Toward HIV Infection). Identification of such molecules may play critical role in design of novel antiviral therapy. In addition, the researchers are examining latently infected, resting CD4+ T cells that are implicated in eradication of virus in infected individuals receiving antiviral therapy (Z01 A1000851-05 Role Of Viral Reservoirs In The Pathogenesis Of HIV Disease). These specimens can only be obtained from 0.2 % of the general HIV patient population and the Canadian Immunodeficiency Research Collaborative has a large cohort of these. Previous services with the CIRC has identified 80 patients meeting our study requirements including 25 long-term non-progressors, and 40 who have been receiving anti-viral therapy for 8 years or more. Many of the aforementioned patients have been reviewed by the NIAID, and currently, our research is wholly dependent on the use of these specimens, which require repeated collation of cells from these patients as part of longitudinal analyses. It is critical that the samples be obtained continuously from these patients for follow-up research studies. Each patient will be subjected to determination of his or her CD4+ T cell count, plasma viral load, and disease status. Contractor will provide 110 medical specimens from designated HIV patients with sample preparation to include Leukopheresis, lymphocyte isolation, in-vitro testing, and cryo-preservation of peripheral blood mononuclear cells. This is not a Small-Business Set Aside. The North American Industry Classification System (NAICS) Code for this acquisition is 621511 and the small-business size standard is $12.5 million dollars. These items will be delivered to a NIAID facility in Bethesda, MD. This is a fixed-price contract and the FOB terms are ?Destination.? The anticipated period of performance will be 03/01/06-02/28/07. FAR provisions and clauses that apply to this acquisition: FAR 52.212-1, Instructions to Offerors Commercial Items; FAR 52.212-3, Offeror Representations and Certifications Commercial Items; FAR 52.212-4, Contractor Terms and Conditions Commercial Items; FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items. FAR 52.225-3. Offerors must include with their offer a completed copy of the provisions at FAR 52.212-3, Offerors Representations and Certifications Commercial Items. Central Contractor Registration (Oct 2003) is required. [Note: Lack of registration in the Central Contractor Registration will make an offeror ineligible for award] Registration is available via the Internet at www.CCR.gov . Offers must be submitted no later than 5:00 P.M. Eastern Standard Time, Monday, February 20, 2006. For delivery of responses through the Postal Service, the address is NIH/NIAID/AMOB, 10401 Fernwood Road, Suite 2NE38E, MSC/4812, Bethesda, Maryland 20817-4812. Electronic submissions will not be accepted. Requests for information concerning this requirement are to be addressed to Arlene White at 301-402-5770. Collect calls will not be accepted.
- Place of Performance
- Address: Delivery to: NIAID Facility, Bethesda, MD
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN00981128-W 20060208/060206212913 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |